SLC7A11 and ovarian carcinoma: SLC7A11 (xCT) in breast cancer regulates cystine/glutamate exchange, influencing ferroptosis and drug sensitivity (67–69), and in ovarian cancer, it is associated with cisplatin resistance via redox balance (72).